Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 48

Sort by

Sort Order Select

Journal Articles

Comparative analysis of toxicity and efficacy of melphalan at doses of 140 mg/m2 VS. 200 mg/m2 as a conditioning regimen prior to autologous stem cell transplantation.

Beatriz Chiclana-Rodríguez, Marta García Culebras, Patricia Alcalde-Mellado, Nancy Rodriguez-Torres, Lucía Mezquita Romero, Juan Luis Reguera, Javier Camuña Correa, Estrella Carrillo-Cruz, Marta Reinoso -Segura, Eusebio Martín Chacón, Laura Pérez Ortega, Jose Francisco Falantes, Cristina Blazquez Go I, Francisco Manuel Martin-Dominguez, Maria Eva Mingot, Virginia Escamilla Gomez, José Antonio Pérez-Simón

Blood (2025) 146 (Supplement 1): 4061.

https://doi.org/10.1182/blood-2025-4061

Published: 2025

Journal Articles

Clinical characteristics, treatment strategies, and response patterns in evans syndrome: Initial analysis from the spanish resti cohort

Maria Eva Mingot, Elena Sebastián Pérez, Javier Bañon Soria, Daniel Martinez Carballeira, Isabel González-gascón-y-Marín, Reyes Jimenez Barcenas, Gonzalo Caballero Navarro, David Valcarcel, Maria Cristina Pascual Izquierdo

Blood (2025) 146 (Supplement 1): 1263.

https://doi.org/10.1182/blood-2025-1263

Published: 2025

Journal Articles

Implementation of 2020 international guidelines in acquired hemophilia: Insights from a decade of national registry data in Spain

Blood (2025) 146 (Supplement 1): 3077.

https://doi.org/10.1182/blood-2025-3077

Published: 2025

Journal Articles

A multicenter, randomized, open-label study of dexamethasone versus romiplostim plus dexamethasone as first line treatment in patients with newly diagnosed immune thrombocytopenia: Interim results of rodex study

Blood (2025) 146 (Supplement 1): 733.

https://doi.org/10.1182/blood-2025-733

Published: 2025

Journal Articles

Switching ITP patients to avatrombopag from other TPO-ras: A real-world experience of the spanish ITP group (GEPTI).

Maria Cristina Pascual Izquierdo, Jose Maria Bastida, David Valcarcel, Blanca Sánchez González, Maria Eva Mingot, Mariana Canaro Hirnyk, Gerardo Aguilar Monserrate, Alicia Ortiz Lopez, Sara Carbonell, Sandra García Lázaro, Anna Martín Carrizosa, Carla Alonso Martinez, Patricia Alcalde Mellado, Begoña Pedrote Amador, Enma Serrasolses Aleman, María Remezal Serrano, Marta Canet Maldonado, Maria del Carmen Gomez Del Castillo, Maialen Lasa Elizalgue, Isabel González-gascón-y-Marín, Denis Zafra, Cristina Fernández Canal, Sonia Piernas Fontanilla, Laura Hernandez Vazquez, Eduardo Morales Espino, Teresa Cobo Rodriguez, Daniel Martinez Carballeira, Patricia Gonzalez Marugan, Estefania Bolaños Caderon, Gonzalo Caballero Navarro, Nuria Revilla-Calvo, Teresa Arquero-Portero, Marta Cervera, Manuel Rodriguez-Lopez, Javier Bañon Soria, Andres Ramirez Lopez, María Teresa Alvarez-Román

Blood (2025) 146 (Supplement 1): 1253.

https://doi.org/10.1182/blood-2025-1253

Published: 2025

Journal Articles

Review of the management of patients with immune thrombotic thrombocytopenic purpura with persistently low adamts-13 activity - a challenge beyond rarity.

Maria Eva Mingot, Inés Gómez Seguí, Maria Cristina Pascual Izquierdo, Faustino García-Candel, Denis Zafra, Lourdes Dominguez-Acosta, Saioa Zalba

Blood (2025) 146 (Supplement 1): 4887.

https://doi.org/10.1182/blood-2025-4887

Published: 2025

Journal Articles

Patient-reported outcomes of avatrombopag for chronic immune thrombocytopenia: Interim analysis of the Phase 4 adopt study

Maria Eva Mingot, María Teresa Alvarez-Román, Maria Lozano, Wolfgang Miesbach, Hafiz Qureshi, Vickie McDonald, Jessica Zhang, Viridiana Cano Garcia, Nina Skuban

Blood (2025) 146 (Supplement 1): 6237.

https://doi.org/10.1182/blood-2025-6237

Published: 2025

Journal Articles

Investigating the Effectiveness and Safety of Combining Thrombopoietin Receptor Agonist and Immunosuppressant Drugs for Patients with Multirefractory Immune Thrombocytopenia after Second-Line Monotherapy Treatments

Blood (2024) 144 (Supplement 1): 3948.

https://doi.org/10.1182/blood-2024-201847

Published: 2024

Journal Articles

Epidemiology of Hereditary Thrombotic Thrombocytopenic Purpura (TTP) in Spain: Preliminary Results of a Study of the Spanish TTP Registry (REPTT)

Inés Gómez Seguí, Maria Cristina Pascual Izquierdo, Maria Eva Mingot, Amanda Lopez Picado, Guillermo Sanz, Javier de la Rubia, Ramon Salinas Argente, Julio Del Rio Garma

Blood (2024) 144 (Supplement 1): 3999.

https://doi.org/10.1182/blood-2024-203666

Published: 2024

Journal Articles

Use of Avatrombopag in Patients with Immune Thrombocytopenia: Interim Analysis of the Phase 4 Adopt Study

María Eva Mingot-Castellano, María Teresa Alvarez-Román, María Luisa Lozano, Wolfgang Miesbach, Hafiz Qureshi, Vickie McDonald, Milica Putnik, Jessica Zhang, Nina Skuban, Viridiana Cano Garcia, Stefan Lethagen

Blood (2024) 144 (Supplement 1): 714.

https://doi.org/10.1182/blood-2024-203491

Published: 2024

Journal Articles

Use of Steroids in Subjects with ITP in Spain: Duration and Toxicity

Blood (2024) 144 (Supplement 1): 1183.

https://doi.org/10.1182/blood-2024-201829

Published: 2024

Journal Articles

ADAMTS13 recovery in acute thrombotic thrombocytopenic purpura after caplacizumab therapy

Blood (2024) 143 (18): 1807–1815.

https://doi.org/10.1182/blood.2023022725

Published: 2024

Includes: Supplemental data

Journal Articles

Avatrombopag Plus Fostamatinib Combination Efficacy and Safety in Patients with Immune Thrombocytopenia

Maria Eva Mingot Castellano, Begoña Pedrote Amador, Riccardo Tomasello, Waleed Ghanima

Blood (2023) 142 (Supplement 1): 2596.

https://doi.org/10.1182/blood-2023-187518

Published: 2023

Journal Articles

Caplacizumab Treatment in Elderly Patients with iTTP: Updated Experience from the Spanish TTP Registry

Blood (2023) 142 (Supplement 1): 5429.

https://doi.org/10.1182/blood-2023-180970

Published: 2023

Journal Articles

Effect of Caplacizumab in the Recovery of ADAMTS13 Level in Patients with Autoimmune Thrombotic Thrombocytopenic Purpura. Analysis from the Spanish Registry (REPTT)

Blood (2023) 142 (Supplement 1): 5394.

https://doi.org/10.1182/blood-2023-182876

Published: 2023

Journal Articles

Caplacizumab Frontline Added to Therapeutic Plasma Exchange and Immunosuppression Prevents Unfavorable Outcomes in Immune-Mediated TTP: An International Real-World Study of the TTP-IWG (The Capla 500 Project)

Blood (2023) 142 (Supplement 1): 2636.

https://doi.org/10.1182/blood-2023-179316

Published: 2023

Journal Articles

Autoimmune hemolytic anemia during pregnancy and puerperium: an international multicenter experience

Bruno Fattizzo, Marta Bortolotti, Norma N. Fantini, Andreas Glenthøj, Marc Michel, Mariasanta Napolitano, Simona Raso, Frederick Chen, Vickie McDonald, Irina Murakhovskaya, Josephine Mathilde Iris Vos, Andrea Patriarca, Maria Eva Mingot-Castellano, Giulio Giordano, Margherita Scarrone, Tomás José González-López, Laura Trespidi, Daniele Prati, Wilma Barcellini

Blood (2023) 141 (16): 2016–2021.

https://doi.org/10.1182/blood.2022018890

Published: 2023

Includes: Supplemental data

Journal Articles

Anxiety and Depression in Patients with Haemophilia a without Inhibitors and Their Caregivers Included in Hemolife, Non Interventional Study in the Spanish Population

María Teresa Alvarez Román, Maria Garcia Dasi, Laura Entrena Ureña, Olga Benitez Hidalgo, Ramiro Jose Nunez Vazquez, Hortensia de la Corte, Alaitz Etxaide Aranbarri, Itziar Guerra, Maria Eva Mingot, Inmaculada Soto

Blood (2022) 140 (Supplement 1): 11326–11327.

https://doi.org/10.1182/blood-2022-157321

Published: 2022

Journal Articles

Pttapp: An Application Developed By the Spanish Society of Hematology and Hemotherapy to Show Practical Recommendations on the Management of Immune TTP

Maria Eva Mingot-Castellano, Rosa Goterris, Moraima Jiménez, Valle Recasens, Saioa Zalba, Marta Fernandez-Docampo, Ana Kerguelen Fuentes, Jose Garcia-Arroba, Inés Gómez-Seguí, David Valcárcel, Cristina Pascual Izquierdo

Blood (2022) 140 (Supplement 1): 5011–5012.

https://doi.org/10.1182/blood-2022-162499

Published: 2022

Journal Articles

Autoimmune Hemolytic Anemia during Pregnancy or Post-Partum: An International Multi-Center Experience

Marta Bortolotti, Norma Fantini, Andreas Glenthøj, Marc Michel, Mariasanta Napolitano, Simona Raso, Frederick Chen, Vickie McDonald, Irina Murakhovskaya, Josephine M.I. Vos, Andrea Patriarca, Maria Eva Mingot, Giulio Giordano, Margherita Scarrone, Laura Trespidi, Daniele Prati, Wilma Barcellini, Bruno Fattizzo

Blood (2022) 140 (Supplement 1): 2440–2442.

https://doi.org/10.1182/blood-2022-156656

Published: 2022

Update search

NARROW

Publications

Format

Subjects

Article Type

Topics

Date

Availability

Comparative analysis of toxicity and efficacy of melphalan at doses of 140 mg/m2 VS. 200 mg/m2 as a conditioning regimen prior to autologous stem cell transplantation.

Clinical characteristics, treatment strategies, and response patterns in evans syndrome: Initial analysis from the spanish resti cohort

Implementation of 2020 international guidelines in acquired hemophilia: Insights from a decade of national registry data in Spain

A multicenter, randomized, open-label study of dexamethasone versus romiplostim plus dexamethasone as first line treatment in patients with newly diagnosed immune thrombocytopenia: Interim results of rodex study

Switching ITP patients to avatrombopag from other TPO-ras: A real-world experience of the spanish ITP group (GEPTI).

Review of the management of patients with immune thrombotic thrombocytopenic purpura with persistently low adamts-13 activity - a challenge beyond rarity.

Patient-reported outcomes of avatrombopag for chronic immune thrombocytopenia: Interim analysis of the Phase 4 adopt study

Investigating the Effectiveness and Safety of Combining Thrombopoietin Receptor Agonist and Immunosuppressant Drugs for Patients with Multirefractory Immune Thrombocytopenia after Second-Line Monotherapy Treatments

Epidemiology of Hereditary Thrombotic Thrombocytopenic Purpura (TTP) in Spain: Preliminary Results of a Study of the Spanish TTP Registry (REPTT)

Use of Avatrombopag in Patients with Immune Thrombocytopenia: Interim Analysis of the Phase 4 Adopt Study

Use of Steroids in Subjects with ITP in Spain: Duration and Toxicity

ADAMTS13 recovery in acute thrombotic thrombocytopenic purpura after caplacizumab therapy

Avatrombopag Plus Fostamatinib Combination Efficacy and Safety in Patients with Immune Thrombocytopenia

Caplacizumab Treatment in Elderly Patients with iTTP: Updated Experience from the Spanish TTP Registry

Effect of Caplacizumab in the Recovery of ADAMTS13 Level in Patients with Autoimmune Thrombotic Thrombocytopenic Purpura. Analysis from the Spanish Registry (REPTT)

Caplacizumab Frontline Added to Therapeutic Plasma Exchange and Immunosuppression Prevents Unfavorable Outcomes in Immune-Mediated TTP: An International Real-World Study of the TTP-IWG (The Capla 500 Project)

Autoimmune hemolytic anemia during pregnancy and puerperium: an international multicenter experience

Anxiety and Depression in Patients with Haemophilia a without Inhibitors and Their Caregivers Included in Hemolife, Non Interventional Study in the Spanish Population

Pttapp: An Application Developed By the Spanish Society of Hematology and Hemotherapy to Show Practical Recommendations on the Management of Immune TTP

Autoimmune Hemolytic Anemia during Pregnancy or Post-Partum: An International Multi-Center Experience

Email alerts

ASH Publications

American Society of Hematology

Update search

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only